Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease. 1982

J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers

The endocytosis of alpha-galactosidase A was studied in cultured fibroblasts from patients with Fabry disease. Alpha-galactosidase A was purified from human placenta by chromatography on concanavalin A-Sepharose, DEAE-cellulose, and N-epsilon-aminocaproyl-alpha-D-galactosylamine-Sepharose. Separation of the high-uptake form of the enzyme from the low-uptake form was accomplished by chromatography on ECTEOLA-cellulose. With the high-uptake form of the enzyme, the uptake was linear at low concentrations of enzyme and had a Kuptake of 0.01 U/ml of medium that corresponds to a Km of 5.0 x 10(-9) M. At high concentrations of enzyme, it became saturated. The high-uptake form could be converted to the low-uptake form by treatment with acid phosphatase. Mannose-6-P strongly inhibited the active uptake of the enzyme. Once taken up into the lysosomes of Fabry disease fibroblasts, alpha-galactosidase A activity was rapidly lost in the first 2 days of incubation at 37 degrees C, but was fairly stable for the next 6 days. The half-life of internalized alpha-galactosidase A activity was calculated to be 4 days. Crosslinking of the enzyme with hexamethylene diisocyanate did not increase the intracellular stability of alpha-galactosidase A activity.

UI MeSH Term Description Entries
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008297 Male Males
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005696 Galactosidases A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-. Galactosidase
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000519 alpha-Galactosidase An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids. Beano,Melibiase,alpha-D-Galactopyranosidase,alpha-D-Galactosidase,alpha-Galactisidase,alpha-Galactosidase A,alpha-Galactosidases,alpha D Galactopyranosidase,alpha D Galactosidase,alpha Galactisidase,alpha Galactosidase,alpha Galactosidase A,alpha Galactosidases

Related Publications

J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
March 1973, Birth defects original article series,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
January 1987, Biochemical and biophysical research communications,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
May 2012, Journal of inherited metabolic disease,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
January 1998, Ryoikibetsu shokogun shirizu,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
December 1995, Nihon rinsho. Japanese journal of clinical medicine,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
August 1973, Pediatric research,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
May 2022, International journal of molecular sciences,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
August 1975, Clinica chimica acta; international journal of clinical chemistry,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
January 2014, Journal of inherited metabolic disease,
J S Mayes, and E L Cray, and V A Dell, and J B Scheerer, and R N Sifers
June 1994, The Journal of the Kentucky Medical Association,
Copied contents to your clipboard!